Carregant...
Optimal composite scores for longitudinal clinical trials under the linear mixed effects model
Clinical trials of chronic, progressive conditions use rate of change on continuous measures as the primary outcome measure, with slowing of progression on the measure as evidence of clinical efficacy. For clinical trials with a single prespecified primary endpoint, it is important to choose an endp...
Guardat en:
| Publicat a: | Pharm Stat |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5132034/ https://ncbi.nlm.nih.gov/pubmed/26223663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1701 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|